Company / Operating Margin
Myriad Genetics, Inc. Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-47.0%
FY2025
5-year range
-47.0% / -14.7%
FY2021-FY2025
Trend
-218.6%
vs FY2024
Sector context
#78 of 135
Health Care
What the data says
Operating Margin changed -219% YoY in FY2025, a notable deviation from the 9-year average annual change of -92%.
Based on SEC 10-K filings.
-47.0% in FY2025 with a 5-year CAGR of -10.7%.
Declined from -34.2% to -47.0% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- -26.2pp
- 5-Year Change
- -10.7pp
- 10-Year Change
- -
Sector benchmark
#78 of 135 in Health CareTop 58% of 135This company -47.0% Sector average -774.4%
▼
+93.9% above sector average
Key checks
Key Insights
- In FY2025, operating margin decreased 218.6% year-over-year.
- Currently 727.5pp above the Health Care sector average.
- Peak operating margin was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score -1.23 (distress zone, below 1.8 threshold)
- Negative profit margin: -15.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -47.0% | -218.6% |
| FY2024 | -14.7% | +56.9% |
| FY2023 | -34.2% | -64.8% |
| FY2022 | -20.7% | +24.8% |
| FY2021 | -27.6% | +24.0% |
| FY2020 | -36.3% | -700.7% |
| FY2019 | 6.0% | -63.1% |
| FY2018 | 16.4% | +187.5% |
| FY2017 | 5.7% | -72.0% |
| FY2016 | 20.3% | +10.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026